Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Recurrent Breast Cancer|Metastastic Breast Cancer
Interventions: DRUG: Gemcitabine and oxaliplatin
Sponsor: University of Southern California